Lululemon Shares Dropped After the Company Cut Its Annual Forecast. Is the Stock a Buy Amid the Selloff?

Lululemon reported Q1 revenue of $2.47 billion, up 4% year over year, but net income fell 38% to $195 million and EPS dropped to $1.69 from $2.60. Management cut full-year guidance to $11.0 billion-$11.15 billion in revenue and $10.95-$11.15 in EPS, citing weaker U.S. sales, poor product launches, and negative brand commentary. The stock is down more than 12% post-earnings, with analyst downgrades and target cuts adding to the bearish tone.

Analysis

The core issue is not a one-quarter miss; it’s a demand-quality problem in the largest profit pool. U.S. weakness at a premium price point suggests the brand has lost some elasticity advantage, so margin pressure is likely to persist even if units stabilize, because the fix requires either heavier promotional spend or product re-merchandising that compresses full-price sell-through. The China growth story is real, but it is not yet large enough to offset U.S. deleveraging, and international mix shift may actually lift reported growth while masking a lower-quality earnings base.

The second-order risk is that management’s reset window extends into the new CEO handoff, which creates a “no accountability” gap for the next two quarters. That matters because any operational fix typically needs at least one full product cycle to show up, so the stock can remain a lagging indicator well into autumn even if sentiment stabilizes. The proxy-fight settlement removes a headline overhang, but it also removes a convenient scapegoat; once the founder noise fades, investors will focus directly on whether product innovation and brand heat are actually improving.

The market may still be underestimating how little room a premium athletic brand has to maneuver when traffic softens: tariffs, freight, and labor inflation are all working against a company that cannot meaningfully discount without damaging long-term brand equity. If the company’s 15% assortment reduction improves productivity, that’s a 2026 story, not a near-term earnings catalyst. Near term, any bounce is likely to be driven more by short-covering and oversold conditions than by fundamental revisions.

The contrarian view is that the setup could become investable only if the stock over-discounts a cyclical reset and the new CEO is given a credible operating runway. But without evidence of same-store sales inflection in the U.S., the risk/reward remains asymmetric to the downside because earnings revisions are still drifting lower. In other words, the market is not just pricing a bad quarter; it is starting to price a multi-quarter brand recovery cycle.

Key Decisions for Investors

• Avoid initiating fresh long exposure to LULU for the next 1-2 quarters; the path to positive revisions likely depends on the next product cycle and CEO transition, not on near-term headlines.
• If forced to play a rebound, use a small 3-6 month call spread on LULU only after evidence of U.S. traffic stabilization; upside can be sharp from oversold levels, but probability remains low until guidance stops resetting.
• Pair trade: short LULU / long NKE over the next 1-3 months. NKE is better positioned to absorb promotion and supply-chain volatility, while LULU’s premium positioning leaves less room to defend volume without margin damage.
• For event-driven traders, wait for post-earnings volatility to fade before considering any tactical short-covering trade; the immediate squeeze risk is highest in the next 1-2 weeks, but the fundamental drift remains negative.
• Watch for a potential November/holiday-season setup: if U.S. comps still lag by then, downside in LULU could extend materially, making put spreads a cleaner risk-defined expression than outright shorts.